Search for stocks /

LIC: ₹21,040 Cr PAT. 53% ROCE.A 96.5% Govt-Owned InsuranceJuggernaut That Won’t Die.

LIC H1 FY26 | EduInvesting
H1 FY26 Results · Half Year Ending Dec 31, 2025

LIC: ₹21,040 Cr PAT. 53% ROCE.
A 96.5% Govt-Owned Insurance
Juggernaut That Won’t Die.

Non-Par booming at 36.5% of APE. VNB margins expanding. Market share still dominating at 57%. The most boring trillion-rupee wealth creator in India is finally catching the market’s attention.

Market Cap₹5,20,136 Cr
CMP₹822
P/E Ratio9.81x
Div Yield1.46%
ROCE53.1%

The Insurance Company That Runs Itself (Seriously)

  • 52-Week High / Low₹980 / ₹731
  • H1 FY26 Premium Income₹2,45,680 Cr
  • H1 FY26 PAT₹21,040 Cr
  • H1 FY26 VNB₹5,111 Cr
  • TTM EPS₹83.8
  • Book Value₹224
  • Price to Book3.66x
  • Dividend Yield1.46%
  • Promoter Holding96.5%
  • 1Yr Return+7.24%
Auditor’s Opening Note: LIC posted H1 FY26 PAT of ₹21,040 crore (a +6.8% H1-on-H1 growth when you annualise the 9-month results to 12 months). Market cap is ₹5.2 lakh crore. It holds 57% of new business premium market share — meaning it’s the undisputed heavyweight in Indian life insurance. CMP ₹822. P/E 9.81x. That’s cheaper than the Nifty 50 median. For a government-owned monopolist printing cash at 53% ROCE. Make of that what you will.

Meet India’s Most Boring ₹5-Lakh-Crore Wealth Creator

LIC stands for Life Insurance Corporation. The first three words are self-explanatory. The fourth is a masterpiece of bureaucratic understatement. It’s not “Corporation” — it’s a dominion. A state-backed apparatus that controls 96.5% of the equity (via the President of India), 57% of the life insurance market, and the financial futures of roughly 30 million Indian households. Literally. The company sold 1.77 crore policies in FY25 alone.

For the uninitiated: LIC does what all insurance companies do, except it does it with the efficiency of a government machine and the profitability of a private cartel. It collects premiums from people who are terrified of dying before their EMIs are paid. It invests that money in bonds, equity, and real estate. It pays claims. The spread between what it earns on investments and what it pays out in claims is where the cash magic happens. And LIC’s management has basically said: “We’re going to get really, really good at this.”

H1 FY26 is the strongest proof point in years. Non-participating products are now 36.5% of APE (Annualized Premium Equivalent), up from 27.68% a year ago. The company expanded VNB margins by 170 basis points YoY to 18.8%. It reduced operating expense ratio to 11.65% (down 132 bps). It’s doing this while competing against SBI Life, HDFC Life, and ICICI Prudential — all of whom are better known and more professionally managed — and yet LIC’s P/E is 9.81x versus their 78x, 76x, and 65x respectively. The discount is almost contemptuous.

Why? Mostly because LIC is government-owned and investors don’t trust governments to not mess things up. Also, dividend policy has been historically stingy: ₹4 (FY24) → ₹10 (FY25) → ₹12 (FY26 expected). That’s movement, but it’s glacial. The company just appointed a new MD (Ramakrishnan Chander took over Dec 1, 2025) and a CFO (Sunil Agarwal’s term extended to March 2027). These are signals that someone wants to run this thing like a real business.

Feb 2026 Concall Note: Management explicitly said they’re “consolidating” rapid gains in Non-Par. They’re not trying to blow the market up. They’re trying to systematically upgrade the business mix and earn more per rupee of premium collected. Very unglamorous. Very effective.

The Insurance Spread Game Explained Like You’re 12.

LIC’s business is almost shockingly straightforward. Step 1: Convince Indians their death is probable and expensive. Step 2: Collect ₹2.45 lakh crore in premiums annually (H1 alone). Step 3: Invest that money at 6–7% average returns in bonds, equity, and real estate. Step 4: Pay out claims for ~98% of maturity obligations and manage the investment spread. Step 5: Repeat for 75 years and become a ₹5-lakh-crore entity.

The product portfolio is split three ways:

Participating Products (Par): These come with bonuses. You pay a premium, LIC invests it, and if returns beat the guaranteed return, you get a slice of the excess. Par products are ~40% of new business mix now, down from 60% five years ago. This is strategic. Par products lock LIC into lower returns because they have to split upside with customers.

Non-Participating Products (Non-Par): These include Unit-Linked Insurance Plans (ULIPs), annuities, and term plans. ULIPs are pure wealth transfer vehicles — the customer takes the market risk, LIC takes the spread. Now 36.5% of APE and growing at 47% YoY. This is the real value driver.

Group Products: Corporate clients, bulk buyouts, and pension schemes. Growing at 13.56% YoY and now 37.39% of total APE. Structurally stable, lower commission drag.

Market Share57%FYP (H1 FY26)
Policies Sold1.17 Cr9M FY26
VNB Margin18.8%+170 bps YoY
Non-Par Growth+47.4%YoY APE

Distribution: 14.87 lakh exclusive agents. But here’s the twist — agency has been losing market share to bancassurance (+66.74% YoY) and alternate channels (+136.42% YoY). LIC is deliberately moving away from the old high-commission agent model toward banks and digital platforms. Banks have lower commission drag. Digital has none.

💬 Quick thought experiment: If LIC sold every product through ULIPs and bancassurance channels only, what would margins look like? Drop your estimate in comments.

H1 FY26: The Numbers That Proved Everyone Wrong

Result type: Half-Yearly Results  |  H1 FY26 PAT: ₹21,040 Cr  |  VNB: ₹5,111 Cr  |  9M PAT (Dec 2025): ₹33,998 Cr

Source table
Metric (₹ Cr) H1 FY26
Sep 2025
H1 FY25
Sep 2024
YoY % 9M FY26*
Dec 2025
9M FY25
Dec 2024
Premium Income245,680221,651+10.8%371,293340,677
Operating Profit10,4749,037+15.9%20,84617,928
OPM %4.3%4.1%+20 bps5.6%5.3%
PAT21,04019,635+7.2%33,99829,158
VNB5,1114,474+14.3%8,2886,474

*9M data is from the Feb 2026 concall (9 months ended Dec 31, 2025). H1 refers to the first half (Apr–Sep 2025) from official results.

The Real Narrative: If you annualise the 9-month PAT of ₹33,998 Cr to a full-year basis (÷ 9 × 12 = ₹45,331 Cr run-rate), LIC is tracking toward full-year PAT well above ₹44 crore. The company guided for operating expense ratio improvement to 11.65% (from 12.97%), which is a 132 basis-point reduction. Mix shift into Non-Par is driving VNB margin expansion of 170 bps. This is fundamental improvement, not one-time benefit.

What’s This Behemoth Actually Worth?

Method 1: P/E Based

TTM EPS = ₹83.8. Industry median P/E for life insurers = 77.3x (per screener). But LIC’s business quality (57% market share, government backing, 53% ROCE) warrants a discount to industry, not a premium. Fair P/E band: 12x–16x (vs peer median 77x).

Range: ₹1,006 – ₹1,341

Method 2: Price to Book Based

Book Value per share: ₹224 (Sep 2025). LIC’s P/B: 3.66x. Insurance companies typically trade at 1.2x–2.5x book given the nature of liabilities. At a justified multiple of 2.0x–2.5x:

Range: ₹448 – ₹560

Method 3: EV/Premium Based

TTM Premium Income (TTM from latest data): ₹9,45,284 Cr. Current EV: ~₹5,20,000 Cr. EV/Premium = 0.55x. Global life insurers trade at 0.8x–1.2x premium multiples. At a normalized 0.9x–1.1x:

EV range: ₹8,51,000 Cr – ₹10,39,800 Cr → Per share (632 Cr shares):

Range: ₹1,345 – ₹1,645

Conservative: ₹800 CMP: ₹822 Aggressive: ₹1,400
CMP ₹822
⚠️ EduInvesting Fair Value Range: ₹900 – ₹1,300. Current price ₹822 appears undervalued relative to intrinsic business quality. This fair value range is for educational purposes only and is not investment advice. Please consult a SEBI-registered investment advisor before making any financial decision.

The Bureaucratic Soap Opera Meets Capitalism

🟢 The Big One: Government Stake Dilution Coming “In The Next Few Months”

LIC is IPO’d but remains 96.5% government-owned. Regulatory requirement: reduce govt holding to 90% within 5 years of IPO (by 2027). Management explicitly stated in the Feb 2026 concall: “you may be hearing about the further tranche… in the next few months.” Translation: Open offer on 6–7% of shares likely by Q3 FY26. At ₹822 CMP, that’s ~₹3,300 crore of selling. Market will absorb it, especially if govt pricing is fair. Question: will the next tranche be at par, or will govt demand a premium to CMP?

⚠️ Headwinds & Operational Challenges

  • • GST Litigation: ₹57+ crore in GST demands for FY21-22 from multiple states (Telangana, Maharashtra, Delhi, Karnataka)
  • • Persistency Weakness: 13-month premium basis down to 75.75% (from 77.34% YoY), policy basis hit to 64.28%
  • • MD Changeover: Ramakrishnan Chander took over Dec 1, 2025; prior MD superannuated Dec 31, 2025
  • • Low Ticket Size Issue: Management acknowledges that low-ticket products have structurally poor persistency
  • • Regulatory Pressure: 100% FDI in insurance could increase competition (not yet live, but signaled)

✅ Momentum & Tailwinds

  • • VNB Margin +170 bps YoY expansion — largest improvement in 5+ years
  • • Non-Par Mix at 36.5% of APE, growing at 47.4% YoY — strategic shift underway
  • • Bancassurance Channel: +66.74% YoY growth with lower commission drag
  • • Bima Sakhi Program: 2.97 lakh rural female agents appointed; ₹1,873 cr NBP in 9M alone
  • • Operating Expense Ratio: down 132 bps to 11.65% — cost discipline in action
  • • IFSC Branch Opened: Feb 27, 2026 at GIFT City, Gandhinagar — international expansion signal
💬 If govt dilutes 6% stake in the next 3 months, does that trigger institutional buying or profit-taking? Your prediction in the comments.

Is The Fort Solid? (Spoiler: Yes, Boring as Hell)

Source table
Item (₹ Cr) Mar 2023 Mar 2024 Mar 2025 Sep 2025
Total Assets4,578,4915,316,0475,660,5685,911,256
Investments (Core)4,243,0084,976,1335,298,4295,571,626
Equity Capital + Reserves39,90876,422120,901135,608
Borrowings0001
Solvency Ratio1.87x1.98x2.11x2.19x
Zero Debt. Literally. Borrowings: ₹1 crore (rounding noise). For an entity managing ₹57+ lakh crore in AUM, this is the definition of fortress balance sheet. Most of the equity capital is from the IPO proceeds (₹6,325 cr). Rest is accumulated reserves.
Investment Grade Assets. ₹55,71,626 Cr in investments as of Sep 2025 — up from ₹52,98,429 Cr a year ago. That’s a 5.2% YoY growth in the asset pool. All of this is driven by premium inflows and investment returns. Zero equity dilution.
Regulatory Comfort Zone. Solvency ratio at 2.19x (Sep 2025) vs regulatory minimum of 1.5x. LIC is over-capitalized by design — good for claim-paying ability, bad for return on capital.

Cash Generation: Steady. Boring. Brilliant.

Source table
Cash Flow (₹ Cr)Mar 2023Mar 2024Mar 2025
Operating CF+54,519+26,548-9,145
Investing CF-52,848-25,695+40,832
Financing CF-949-4,427-3,794
Net CF+722-3,574+27,893

Note: Insurance company cash flows are notoriously volatile due to the nature of premium collection and claims payouts. The “Operating CF” in FY25 (-₹9,145 Cr) reflects elevated claim payouts in Q4 (maturity season) relative to premium receipts timing.

Premium Inflows = The Real OCF. LIC collected ₹9.45 lakh crore in premium (TTM). Operating CF volatility is just timing. The company is fundamentally cash-generative at the premium level.

The Metrics Don’t Lie

ROE45.7%3yr avg: 62.9%
ROCE53.1%vs Industry Avg
P/E9.81xPeer Median: 77.3x
OPM5.7%Improving trend
Debt / Equity0.00x
AUM / Asset Base₹59.2 Lakh Cr
Profit Growth (5yr)+77.7%
Earnings Yield12.4%
The P/E discount is the story. LIC trades at 9.81x TTM EPS while peers trade at 65x–78x. This is partly justified (government ownership, policy risk) but mostly irrational given the 53% ROCE and fortress balance sheet. When (not if) the govt stake dilution is completed, institutional money will likely reassess this valuation.

Annual Trends — FY23 to TTM

Source table
Metric (₹ Cr)Mar 2023Mar 2024Mar 2025TTM (9M+Q4 est.)
Premium Income784,628845,966889,970945,284
Operating Profit34,13032,65153,27853,846
OPM %4%4%6%5.7%
PAT35,99740,91648,32052,998
EPS (₹)56.9164.6976.4083.83
Premium CAGR (3yr)+6.9%
PAT CAGR (3yr)+20.8%
EPS CAGR (3yr)+21.7%

Profitability is outpacing revenue growth — this is the operational leverage story. Premium growth at ~7% is tied to market growth, but profit growth at 21% reflects mix improvement and cost discipline. This is the exact trajectory that drives valuation re-rating.

LIC vs The Actual Competitors (Who Are Getting Destroyed)

Source table
CompanyCMP (₹)P/EP/BROCE %ROE %Market Cap (Cr)
Life Insurance8229.813.6653.1345.7520,136
SBI Life1,94278.4610.2416.8815.13194,516
HDFC Life66976.118.206.5810.80143,869
ICICI Pru61464.956.6111.9410.4388,933
Max Financial1,702408.8011.078.137.2658,733

The Roast: Every single peer is more expensive than LIC despite LIC’s superior ROCE and ROE. SBI Life trades at 78x P/E despite earning half what LIC earns on capital. HDFC Life has a ROCE of 6.58% — that’s worse than a fixed deposit. Max Financial is literally off the charts at 408x P/E. And LIC? It’s the cheapest on quality-adjusted basis by a factor of 7–8x. Either the market is right and LIC is deserving of a massive discount, or the market is completely mis-pricing the largest insurance company in the country.

💬 Poll: Is LIC cheap or is it cheap for a reason? (Government ownership = higher execution risk?) Your nuanced take in comments.

Who Owns This Monopoly?

Promoter 96.5% President of India
  • Promoters (Govt)96.50%
  • FIIs0.20%
  • DIIs1.33%
  • Public1.96%

No pledges. No Adani controversies (despite the 2024 media saga). Clean cap table.

The Government Owner

President of India (via the Ministry of Finance) holds 96.5% through its shareholding route. IPO in 2021 saw 9.5% dilution. Regulatory mandate: reduce to 90% within 5 years (by 2027). Next tranche “in the next few months” per Feb 2026 concall.

Management Leadership

New MD Ramakrishnan Chander took charge Dec 1, 2025 (term until Sep 30, 2027). CFO Sunil Agarwal’s term extended to March 2027. Prior MD superannuated Dec 31, 2025. Signaling: fresh blood, strategic reorientation underway.

The Good, The Bad, and The Regulatory

✅ Strengths

  • ✓ Zero debt — fortress balance sheet
  • ✓ 2.19x solvency ratio (well above 1.5x minimum)
  • ✓ Clean audit history — no material qualifications
  • ✓ Board composition includes government and independent directors
  • ✓ Active concall cadence — management transparency improving

⚠️ Watch List

  • ⚠ GST litigation in multiple states (₹57+ crore demands)
  • ⚠ Dividend policy still underdeveloped (₹4 → ₹10 → ₹12)
  • ⚠ Persistency softening (13M down to 75.75% from 77.34%)
  • ⚠ Government ownership = execution risk + policy changes
  • ⚠ Regulatory changes could impact product profitability

Insurance: The Sector Where Everyone Pretends to Be Sophisticated

Market context: India’s life insurance penetration is ~3.2% of GDP, vs 7–10% in developed markets. That’s structural tailwind for 20+ years. The market grows at 6–8% annually, driven by rising incomes, financial awareness, and mandate-driven demand (PMJJBY, APY, etc.). LIC captures 57% of new business premium. The next four players combined have ~35%. The math is not complicated.

🔴 The Structural Threat: Mortality Compression

Indians are living longer. Life expectancy increased from 65 years (2010) to 72 years (2025). This is terrible for term insurance sellers (lower claims, lower premiums) but fine for endowment/whole-life products. LIC’s mix is biased toward traditional endowments, which benefits from longevity. But on aggregate, mortality compression is a long-term headwind for the sector.

🟢 The Opportunity: ULIPs and Non-Par Growth

Non-Participating products (ULIPs, annuities, term plans) are 36.5% of LIC’s APE and growing at 47% YoY. These products have structurally higher margins (no bonus obligation) and are where all growth is coming from. SBI Life and HDFC Life have been Non-Par focused for years. LIC’s late pivot is actually a huge opportunity — the company can copy their playbook while leveraging distribution scale.

🔵 The Wildcard: Government Policy Volatility

LIC’s dividend policy is subject to government whims. Commission regulations could change overnight. Pension asset regulations could shift. 100% FDI in insurance could increase competition. The company is too big and too important for the government to let fail, but also too important for the government to not interfere. This uncertainty is why the P/E discount exists.

⚡ The Tailwind: Digital Transformation + Rural Penetration

LIC’s Bima Sakhi program has appointed 2.97 lakh rural female agents in just 2–3 years. These agents sold ₹1,873 Cr in new business premium in 9 months alone. Traditional distribution would take decades to achieve this. Bancassurance channel is growing 67% YoY with lower cost structure. Digital adoption (ANANDA app) is rising 41% YoY. The infrastructure for 3x growth exists and is being deployed.

💬 Here’s a thought: If LIC’s Non-Par mix reaches 50% of APE (where global insurers operate), what happens to VNB margins? Estimate in the comments.

The Insurance Disruptor That Runs On Inertia

📊

LIC is the most mis-priced megacap in Indian equities. The company controls 57% of the life insurance market. It earns 53% ROCE. It has zero debt. It grew PAT at 21% CAGR over three years. And the stock trades at 9.81x P/E — cheaper than the Nifty 50, despite being objectively superior on nearly every metric. If you believe in mean reversion in valuation, this is the trade.

H1 FY26 Execution: VNB margin expansion of 170 bps is the most important data point. This shows that management’s strategy to pivot toward Non-Par products and lower-commission channels is actually working. Operating expense ratio compression by 132 bps proves cost discipline. Non-Par APE growing at 47% YoY proves the market wants these products. This is not a one-off. This is a business inflection.

The Government Ownership Question: Yes, 96.5% government ownership is a double-edged sword. On one hand: policy risk, dividend policy uncertainty, potential political interference. On the other hand: implicit backstop on solvency, regulatory favoritism, brand power. The dilution from 96.5% to 90% (required by 2027) could be the catalyst that institutional money reassesses this valuation. When foreign investors can be majority owners, suddenly a 9.81x P/E looks criminally cheap.

Historical Context: LIC’s stock has been flat for 5 years (since IPO in 2021 at ₹949). That’s mostly because investor expectations of government PSUs are so low that even 20%+ profit growth doesn’t surprise the market. The company paid out ₹4 → ₹10 → ₹12 in dividends (improving but slow). Now, with a new MD and refocused strategy, there’s a window for re-rating.

✓ Strengths

  • 57% market share — undisputed category leader
  • 53% ROCE — superior capital efficiency
  • Zero debt — fortress balance sheet
  • 14.87 lakh agent base + 2.97 lakh Bima Sakhis — unmatched reach
  • VNB margin expansion of 170 bps YoY — strategic inflection
  • Non-Par at 47% YoY growth — structural mix improvement

✗ Weaknesses

  • Government ownership (96.5%) = policy risk
  • Dividend policy historically stingy (payout ~1.5% of earnings)
  • Persistency declining (75.75% vs 77.34% YoY) — low-ticket issue
  • Profitability tied to investment returns — interest rate sensitive
  • Traditional products still ~40% of mix — legacy drag
  • GST litigation in multiple states — ₹57+ crore exposure

→ Opportunities

  • Government stake dilution (96.5% → 90%) by 2027 — valuation re-rating trigger
  • Non-Par mix expansion (currently 36.5% → potential 50%+)
  • Bancassurance scale-up (currently 7.45% of NBP, growing 67% YoY)
  • Rural penetration via Bima Sakhi (untapped market)
  • Digital transformation (ANANDA app +49.42% YoY adoption)
  • Pension/annuity growth (regulatory tailwind on retirement savings)

⚡ Threats

  • Mortality compression (Indians living longer = lower claims)
  • 100% FDI in insurance could intensify competition
  • Regulatory changes on commissions/product design
  • Interest rate volatility affects investment returns
  • Persistency softening due to low-ticket product mix
  • Shift toward term/digital-only players from startups

In the hierarchy of mis-priced mega-caps, LIC sits at the apex. The company is a cash-printing machine, the market owns it like a PSU, and the valuation reflects 2010s sentiment.

H1 FY26 results prove the business is in transition: margin expansion, mix upgrade, cost discipline, and distribution modernization all happening simultaneously. Government stake dilution is coming within 12 months. When that happens, institutional money will likely realize that a 53% ROCE asset trading at 9.81x P/E is not a tragedy of the commons — it’s a typo in Excel.

The business is boring. The returns could be anything but.

⚠️ EduInvesting Fair Value Range: ₹900 – ₹1,300. This analysis is strictly for educational purposes and does not constitute investment advice. Please consult a SEBI-registered investment advisor before making any financial decision.
error: Content is protected !!